Profile | GDS5420 / 224090_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 127.72 | 45 |
GSM1296119 | B_lesional_pre-dose | 156.12 | 47 |
GSM1296076 | C_lesional_pre-dose | 134.11 | 47 |
GSM1296092 | D_lesional_pre-dose | 91.97 | 42 |
GSM1296103 | E_lesional_pre-dose | 113.63 | 44 |
GSM1296078 | F_lesional_pre-dose | 128.9 | 47 |
GSM1296107 | G_lesional_pre-dose | 235.46 | 55 |
GSM1296109 | H_lesional_pre-dose | 117.1 | 42 |
GSM1296080 | I_lesional_pre-dose | 62.43 | 36 |
GSM1296090 | J_lesional_pre-dose | 64.84 | 36 |
GSM1296074 | K_lesional_pre-dose | 22.34 | 21 |
GSM1296111 | L_lesional_pre-dose | 141.7 | 45 |
GSM1296099 | M_lesional_pre-dose | 132.95 | 46 |
GSM1296086 | O_lesional_pre-dose | 88.63 | 41 |
GSM1296117 | P_lesional_pre-dose | 315.56 | 59 |
GSM1296113 | Q_lesional_pre-dose | 296.15 | 58 |
GSM1296096 | R_lesional_pre-dose | 80.47 | 39 |
GSM1296105 | S_lesional_pre-dose | 68.99 | 35 |
GSM1296098 | T_lesional_pre-dose | 104.6 | 41 |
GSM1296101 | U_lesional_pre-dose | 69.01 | 35 |
GSM1296121 | V_lesional_pre-dose | 182.97 | 50 |
GSM1296088 | W_lesional_pre-dose | 79.98 | 39 |
GSM1296082 | X_lesional_pre-dose | 88.25 | 41 |
GSM1296115 | Y_lesional_pre-dose | 188.58 | 51 |
GSM1296084 | Z_lesional_pre-dose | 66.58 | 35 |
GSM1296072 | B_lesional_day8 | 173.02 | 49 |
GSM1296069 | L_lesional_day8 | 169.17 | 47 |
GSM1296071 | P_lesional_day8 | 199.02 | 50 |
GSM1296070 | Y_lesional_day8 | 199.93 | 51 |
GSM1296073 | V_lesional_day8 | 139.25 | 47 |
GSM1296034 | A_lesional_day15 | 47.38 | 29 |
GSM1296041 | G_lesional_day15 | 295.27 | 59 |
GSM1296035 | R_lesional_day15 | 61.89 | 36 |
GSM1296038 | U_lesional_day15 | 110.87 | 43 |
GSM1296047 | B_lesional_day15 | 198.24 | 51 |
GSM1296039 | E_lesional_day15 | 77.41 | 38 |
GSM1296042 | H_lesional_day15 | 239.87 | 54 |
GSM1296043 | L_lesional_day15 | 200.35 | 51 |
GSM1296037 | M_lesional_day15 | 75.72 | 36 |
GSM1296046 | P_lesional_day15 | 251.51 | 55 |
GSM1296044 | Q_lesional_day15 | 328 | 59 |
GSM1296045 | Y_lesional_day15 | 190.01 | 49 |
GSM1296025 | C_lesional_day15 | 90.32 | 40 |
GSM1296033 | D_lesional_day15 | 73.89 | 37 |
GSM1296027 | I_lesional_day15 | 66.05 | 38 |
GSM1296032 | J_lesional_day15 | 69.94 | 36 |
GSM1296024 | K_lesional_day15 | 59.62 | 35 |
GSM1296031 | W_lesional_day15 | 44.86 | 29 |
GSM1296028 | X_lesional_day15 | 92.39 | 41 |
GSM1296029 | Z_lesional_day15 | 27.58 | 23 |
GSM1296026 | F_lesional_day15 | 80.9 | 39 |
GSM1296030 | O_lesional_day15 | 48.66 | 34 |
GSM1296040 | S_lesional_day15 | 151.77 | 48 |
GSM1296036 | T_lesional_day15 | 86 | 38 |
GSM1296048 | V_lesional_day15 | 182.18 | 50 |
GSM1296059 | A_lesional_day43 | 88.56 | 40 |
GSM1296066 | G_lesional_day43 | 335.62 | 61 |
GSM1296060 | R_lesional_day43 | 79.18 | 38 |
GSM1296063 | U_lesional_day43 | 128.95 | 45 |
GSM1296064 | E_lesional_day43 | 95.85 | 41 |
GSM1296067 | H_lesional_day43 | 181.5 | 49 |
GSM1296062 | M_lesional_day43 | 90.12 | 40 |
GSM1296068 | Q_lesional_day43 | 233.3 | 53 |
GSM1296050 | C_lesional_day43 | 87.51 | 39 |
GSM1296057 | D_lesional_day43 | 52.46 | 32 |
GSM1296052 | I_lesional_day43 | 56.24 | 35 |
GSM1296054 | J_lesional_day43 | 67.91 | 35 |
GSM1296049 | K_lesional_day43 | 80.56 | 38 |
GSM1296055 | W_lesional_day43 | 85.25 | 38 |
GSM1296053 | X_lesional_day43 | 79.25 | 38 |
GSM1296058 | Z_lesional_day43 | 30.25 | 26 |
GSM1296051 | F_lesional_day43 | 76.84 | 38 |
GSM1296056 | O_lesional_day43 | 48.31 | 32 |
GSM1296065 | S_lesional_day43 | 152.24 | 48 |
GSM1296061 | T_lesional_day43 | 49.2 | 30 |
GSM1296095 | A_non-lesional_pre-dose | 155.19 | 49 |
GSM1296120 | B_non-lesional_pre-dose | 146.89 | 46 |
GSM1296077 | C_non-lesional_pre-dose | 50.12 | 32 |
GSM1296093 | D_non-lesional_pre-dose | 23.72 | 19 |
GSM1296104 | E_non-lesional_pre-dose | 119.41 | 44 |
GSM1296079 | F_non-lesional_pre-dose | 102.12 | 42 |
GSM1296108 | G_non-lesional_pre-dose | 217.66 | 53 |
GSM1296110 | H_non-lesional_pre-dose | 283.27 | 57 |
GSM1296081 | I_non-lesional_pre-dose | 11.89 | 13 |
GSM1296091 | J_non-lesional_pre-dose | 105.71 | 43 |
GSM1296075 | K_non-lesional_pre-dose | 108.75 | 44 |
GSM1296112 | L_non-lesional_pre-dose | 214.28 | 51 |
GSM1296100 | M_non-lesional_pre-dose | 41.14 | 28 |
GSM1296087 | O_non-lesional_pre-dose | 38.11 | 29 |
GSM1296118 | P_non-lesional_pre-dose | 213.73 | 52 |
GSM1296114 | Q_non-lesional_pre-dose | 315.1 | 59 |
GSM1296097 | R_non-lesional_pre-dose | 74.81 | 37 |
GSM1296106 | S_non-lesional_pre-dose | 151.34 | 47 |
GSM1296102 | U_non-lesional_pre-dose | 67.1 | 34 |
GSM1296122 | V_non-lesional_pre-dose | 59.09 | 31 |
GSM1296089 | W_non-lesional_pre-dose | 151.11 | 47 |
GSM1296083 | X_non-lesional_pre-dose | 39.52 | 28 |
GSM1296116 | Y_non-lesional_pre-dose | 223.06 | 52 |
GSM1296085 | Z_non-lesional_pre-dose | 30.87 | 24 |